Cingulate Stock (NASDAQ: CING) stock price, news, charts, stock research, profile.
You can purchase shares of Cingulate (NASDAQ:CING) through any online brokerage.
Other companies in Cingulate’s space includes: Cumberland (NASDAQ:CPIX), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
Cingulate has a consensus price target of $8.50.
The stock price for Cingulate (NASDAQ: CING) is $3.9 last updated October 31, 2024 at 4:38 PM EDT.
There are no upcoming dividends for Cingulate.
Cingulate’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Cingulate.
Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.